{"id":18702,"date":"2024-12-18T17:15:20","date_gmt":"2024-12-18T09:15:20","guid":{"rendered":"https:\/\/flcube.com\/?p=18702"},"modified":"2024-12-18T17:15:23","modified_gmt":"2024-12-18T09:15:23","slug":"microport-cardioflow-medtechs-vitaflow-liberty-flex-receives-nmpa-approval","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=18702","title":{"rendered":"MicroPort CardioFlow Medtech’s VitaFlow Liberty Flex Receives NMPA Approval"},"content":{"rendered":"\n

MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160<\/a>), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.<\/p>\n\n\n\n

VitaFlow Liberty Flex: Enhancing TAVI Procedure Precision<\/strong>
VitaFlow Liberty Flex is an upgraded version of the second-generation TAVI product, VitaFlow Liberty, and introduces a new 3D spatial bending function to the market. This innovative feature, along with its unique inner tube bending technology, maintains the valve’s coaxiality during the release process. This enhancement leads to a more stable and precise implantation, ensuring a smoother and safer passage through the aortic arch and valve.<\/p>\n\n\n\n

Advantages and Safety Features of VitaFlow Liberty Flex<\/strong>
One of the standout features of VitaFlow Liberty Flex is its ability to align valve release boundaries, which protects coronary pathways and reserves space for potential future coronary interventions. This design consideration is particularly important for patients who may require additional cardiac procedures in the future, showcasing the product’s forward-thinking approach to patient care.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry…<\/p>\n","protected":false},"author":1,"featured_media":18703,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[69,1133,812,15],"class_list":["post-18702","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-cvd","tag-hkg-2160","tag-microport-cardioflow-medtech","tag-product-approvals"],"yoast_head":"\nMicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=18702\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval\" \/>\n<meta property=\"og:description\" content=\"MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=18702\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T09:15:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-18T09:15:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"566\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"MicroPort CardioFlow Medtech’s VitaFlow Liberty Flex Receives NMPA Approval\",\"datePublished\":\"2024-12-18T09:15:20+00:00\",\"dateModified\":\"2024-12-18T09:15:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702\"},\"wordCount\":207,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1809.png\",\"keywords\":[\"CVD\",\"HKG: 2160\",\"MicroPort CardioFlow Medtech\",\"Product approvals\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=18702#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=18702\",\"name\":\"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1809.png\",\"datePublished\":\"2024-12-18T09:15:20+00:00\",\"dateModified\":\"2024-12-18T09:15:23+00:00\",\"description\":\"MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=18702\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1809.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1809.png\",\"width\":1080,\"height\":566,\"caption\":\"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18702#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MicroPort CardioFlow Medtech’s VitaFlow Liberty Flex Receives NMPA Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval - Insight, China's Pharmaceutical Industry","description":"MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=18702","og_locale":"en_US","og_type":"article","og_title":"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval","og_description":"MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.","og_url":"https:\/\/flcube.com\/?p=18702","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-12-18T09:15:20+00:00","article_modified_time":"2024-12-18T09:15:23+00:00","og_image":[{"width":1080,"height":566,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=18702#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=18702"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"MicroPort CardioFlow Medtech’s VitaFlow Liberty Flex Receives NMPA Approval","datePublished":"2024-12-18T09:15:20+00:00","dateModified":"2024-12-18T09:15:23+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=18702"},"wordCount":207,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=18702#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png","keywords":["CVD","HKG: 2160","MicroPort CardioFlow Medtech","Product approvals"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=18702#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=18702","url":"https:\/\/flcube.com\/?p=18702","name":"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=18702#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=18702#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png","datePublished":"2024-12-18T09:15:20+00:00","dateModified":"2024-12-18T09:15:23+00:00","description":"MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=18702#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=18702"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=18702#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png","width":1080,"height":566,"caption":"MicroPort CardioFlow Medtech's VitaFlow Liberty Flex Receives NMPA Approval"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=18702#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"MicroPort CardioFlow Medtech’s VitaFlow Liberty Flex Receives NMPA Approval"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1809.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18702"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18702\/revisions"}],"predecessor-version":[{"id":18704,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18702\/revisions\/18704"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/18703"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}